Monika Brink, PhD Boehringer Ingelheim International

Monika studied chemistry in Bielefeld from 1984 to 1994, with focus on organic chemistry for her scientific work. Since then, she has gained more than 20 years of experience in the agrochemical and pharmaceutical industry.

Starting in the chemical development of American Cyanamid, she moved to production with co-leading an API launch production plant at Sanofi-Aventis for 5 years.

From 2005 onwards, she focused on outsourcing of pharmaceutical development activities in the Animal Health business, including 5 years at Intervet and more than 8 years at Boehringer Ingelheim Vetmedica.

Her outsourcing responsibilities included API and drug product development, analytical activities, primary packaging and device development, as well as technical transfer activities.

In September 2018, she moved to Human Pharma within Boehringer into the third party management.